BREAST CANCER

Menopause drug Livial ups breast cancer return risk

IBTimes Logo
LONDON (Reuters) - The synthetic hormone Livial, designed as an alternative to hormone replacement therapy, makes it significantly more likely a woman's breast cancer will come back, Dutch researchers said on Tuesday.
More news
IBTimes Logo

'Virtual walk': Charity meets technology

Want to walk for a good cause but find yourself strapped for time or physically incapable? Welcome to the virtual walk where you can raise money for charity without ever stepping out the front door.
IBTimes Logo

GSK Submits Tykerb for Market Approval

GlaxoSmithKine plc has announced today the submission of a New Drug Application to the United States Food and Drug Administration (FDA), for approval to market.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.